CME Group Inc. (CME Holdings) 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2007, and the six months ended on that date. The registrant is Chicago Mercantile Exchange Holdings Inc. (CME Holdings). Effective July 12, 2007, CME Holdings merged with CBOT Holdings to form CME Group Inc. The financial statements in this report reflect only CME Holdings and its subsidiaries prior to the merger. The company operates as a derivatives exchange, providing trading, clearing, and data services.
Key Financial Metrics
| Metric | Q2 2007 | Q2 2006 | 6 Months 2007 | 6 Months 2006 |
|---|---|---|---|---|
| Total Revenues | $329.0 million | $282.2 million | $661.3 million | $533.9 million |
| Net Income | $125.9 million | $109.5 million | $255.9 million | $200.9 million |
| Operating Income | $192.2 million | $166.8 million | $392.8 million | $305.6 million |
| Operating Margin | 58% | 59% | 59% | 57% |
| Cash Earnings (Non-GAAP) | N/A | N/A | $259.4 million | $199.9 million |
| Diluted EPS | $3.57 | $3.12 | $7.26 | $5.73 |
| Cash & Equivalents | $1,174.9 million | N/A | $1,174.9 million | $782.1 million |
| Debt | None reported | None reported | None reported | None reported |
Note: The company maintains an $800 million line of credit and a new $3.0 billion revolving loan facility entered into in July 2007, but no long-term debt was outstanding as of June 30, 2007.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 17% in Q2 and 24% year-to-date (YTD). This was driven by a 19% YTD increase in clearing and transaction fees and an 89% YTD surge in processing services revenue.
- Volume vs. Rate: Average daily trading volume increased 19% YTD, but the average rate per contract decreased 1% YTD due to higher volumes of member trades (which receive lower fees) and increased incentives/discounts.
- Expense Increases: Total expenses rose 19% in Q2 and 18% YTD. Key drivers included higher compensation (16% YTD increase), marketing (85% YTD increase due to merger branding), and professional fees (20% YTD increase due to merger integration).
- Processing Services: Revenue from the NYMEX agreement and CBOT volume growth contributed significantly to the 89% YTD increase in processing services revenue.
Guidance, Outlook, and Risks
- Merger Integration: The company is finalizing staffing, technology, and facilities plans for the CBOT merger. Material restructuring charges are expected in the second half of 2007, though the amount is not yet determinable.
- Share Repurchase: On August 1, 2007, the company commenced a tender offer to repurchase up to 6.25 million shares at $560 per share (approx. $3.5 billion total). Funding will come from cash, commercial paper, and a new $3.0 billion revolving credit facility.
- Legal Contingencies: A class action lawsuit (LAMPERS) regarding the CBOT merger settlement is expected to cost up to $7.4 million in legal fees, to be recognized in Q3 2007. An ongoing antitrust suit by Eurex U.S. is being vigorously defended.
- Product Changes: The license for Russell-based contracts terminates in September 2007, to be replaced by S&P 600 Index contracts.
- Risk Factors: Risks include the ability to realize merger synergies, dependence on third-party suppliers, regulatory changes, and the impact of market volatility on trading volumes.
Investor Verification Checklist
- Verify the final amount of restructuring charges expected in H2 2007 related to the CBOT merger integration.
- Confirm the final settlement amount and timing for the LAMPERS litigation (capped at $7.4 million).
- Monitor the execution of the $3.5 billion share repurchase tender offer and its impact on liquidity.
- Assess the transition of CBOT products to the CME Globex platform and associated cost synergies.
- Review the impact of the expiring Russell contract license on Q3 and Q4 trading volumes.